Radiolabelled antimicrobial peptides for infection detection

Area of Science:

• Nuclear Medicine
• Infectious Diseases
• Biomedical Imaging

Background:

• Differentiating infectious from non-infectious febrile episodes is clinically challenging.
• Scintigraphic imaging using radiolabeled antimicrobial peptides presents a potential diagnostic tool.

Purpose of the Study:

• To evaluate technetium-99m (99mTc)-labeled antimicrobial peptides for scintigraphic imaging of infections.
• To assess the peptides' ability to differentiate infectious from sterile inflammatory sites.
• To determine if these peptides can monitor antimicrobial therapy efficacy.

Main Methods:

• Selection of 99mTc-antimicrobial peptides based on binding characteristics and clearance rates.
• Imaging of experimental infections in laboratory animals using selected peptides.
• Correlation of peptide accumulation with viable microbial load.
• Monitoring of antimicrobial therapy efficacy in infected animal models.

Main Results:

• Selected 99mTc-antimicrobial peptides demonstrated favorable binding to bacteria and fungi, accumulating at infection sites.
• Peptides effectively distinguished infectious foci from sterile inflammatory lesions.
• Accumulation of 99mTc-antimicrobial peptides correlated with the number of viable microorganisms.
• The peptides successfully monitored the efficacy of antimicrobial therapy in experimental infections.

Conclusions:

• Non-microbicidal 99mTc-antimicrobial peptides are promising for scintigraphic imaging of bacterial and fungal infections.
• These peptides show potential for monitoring antimicrobial therapy effectiveness in patients.
• This approach could aid in diagnosing febrile episodes of unclear origin.